Qusel Xr Tablets 150Mg

Product Overview

Product Form: Tablet
Pack Size: 150mg
Manufactured By: HILTON PHARMACEUTICALS
Prescription Required: Yes

Product Details

Qusel XR 150mg Tablets contain Quetiapine Fumarate, an extended-release formulation used to treat schizophrenia. Quetiapine works by blocking dopamine D2 and serotonin 5HT2 receptors, helping to stabilize mood and reduce symptoms such as hallucinations, disorganized thinking, and mood swings. The extended-release formulation of 150mg allows for a more sustained release of the medication, helping manage symptoms over an extended period.

Purposes

Qusel XR 150mg is prescribed for the treatment of schizophrenia, a condition characterized by disruptions in thinking, emotions, and behavior. This medication helps alleviate symptoms like delusions, auditory and visual hallucinations, and other cognitive impairments, thereby improving the patient’s quality of life.  helps individuals regain mental stability by balancing chemicals in the brain.

Warnings

1. Neuroleptic Malignant Syndrome: This rare but serious condition may occur with the use of Qusel XR 150mg. Symptoms such as muscle rigidity, fever, and altered mental status should be reported immediately for medical attention.

2. Tardive Dyskinesia: Long-term use of Quetiapine can cause involuntary muscle movements. If this occurs, discontinuation of  may be necessary.

3. Eye Examinations: Regular eye exams should be conducted before starting  150mg and every six months thereafter, as the medication can cause changes in vision.

Adverse Effects

The common side effects associated with 150mg include drowsiness, dizziness, dry mouth, constipation, and postural hypotension. Weight gain and elevated liver enzymes are also possible. It is important to discuss any persistent or concerning side effects with a healthcare provider.

Cautions

Qusel XR 150mg should be used with caution in individuals with liver or kidney issues, cardiovascular disease, or those prone to hyperglycemia. Patients with a history of seizures or difficulty regulating body temperature should inform their healthcare provider before starting the medication. The safety of this medication in pediatric patients under 18 has not been established.